OMKAR PHARMACHEM LIMITED

CIN L24231 GJ1995PLC025276

501, Mahakant Building,
Opp. V.S. Hospital,
Ashram road, Ellisbridge,
Ahmedabad-380 006.
Website www.omkarpharmachem.co.in
Email investors.opl@gmail.com

Date: 14/08/2016
To,
Bombay Stock Exchange Limited,
Phiroz Jeejeebhoy Towers,
Dalal Street,
Mumbai-400001
Sub: - Unaudited Quarterly Financial Result under Regulation 33 of the
of the SEBI (Listing Obligation And Disclosure Requirement) Regulation
2015. for the Quarter ended 30th June. 2016
Company Scrip Code: 532167
Dear Sir,
Pursuant to the provisions of Regulation 33 of the of the SEBI (Listing
Obligation And Disclosure Requirement) Regulation 2015, please find enclosed
herewith, copy of the Unaudited Quarterly Financial Results of the Company, for
the Quarter ended 30th June, 2016" for your kind perusal and reference.
The aforesaid result has been approved by the Board of Directors at their
meeting held on 14thAugust, 2016.
This is for your information and record.
Thanking You,
Yours faithfully,
For Omkar Pharmachem

Limited

~~

(Anurag Sharma)
Managing Director
DIN 02289261
Add: A-727, Sarita Vihar, New Delhi, 110076
Encl: a/a

OMKAR PHARMACHEM

LIMITED

Regd. Off. SOl, Mahakant Bulding, opp: V.S. Hospital, Ashram Road, Ellisbridge, Ahmedabad-380006
CrN: L24231GJl995PLC025276
Statement

Website:

of Standalone

Audited

www.omkarphannachem.co.in

Results for the Quarter

Email: investors.opl@gmail.com

and Year Ended on 30th June 2016

(Rs in lacs except per share data)

(Refer notes Below)

No.
I

Quarter

Particulars

Sr.

6
7

30-06-2016

31-3-2016

30-06-2015

31-03-2016

(unaudited)

(audited)

(unaudited)

(audited)

0.00

0.00

0.00

b)Other Operating Income

0.00

0.00

0.00

Total income from Operations

0.00

0.00

0.00

0.00
0.00
0.00

2.64

0.94

0.62

2.79

0.06
2.74
5.44

2.07

3.58

9.06

3.01

4.20

11.85

-5.44
0.25

-3.01
0.03

-4.20
0.11

-11.85
0.14

-5.19

-2.98
0.00

-4.09
0.00

-11.71

0.00
-5.19
48.19

-2.98
0.00

-4.09

-11.71

0.00

0.00

43.00
5.17

-2.98

-4.09

-11.71

0.00

0.00

0.00

37.83

-2.98

-4.09

-11.71

1008.37

1008.37

1008.37

1008.37

-92.71

-81.00

-81.00

-81.00

0.3752

-0.0296

-0.0406

-0.1161

Expenses
a) Employee benefits expense
and amortization

expenses

b) Other Expenses
Total Expenses

4
5

Year ended on

Income from operations

a)Net Salesllncome from Operations

b) Depreciation

Ended on

Profit(Loss)

from operations

cost and exceptional

Other Income
Profit(Loss)

before Other

income, Finance

items(I-2)

before Finance

cost and exceptional

items(3+4)

Finance Costs
Profit(Loss)

from Ordinary

before exceptional
exceptional items

Profit(Loss)

Activities

before Tax( 7-8)

for the period (9-10)

12 Paid up Equity Share Capital (Face Value Rs. IO/-each)

13 Reserves excluding Revaluation Reserves as per Balancesheet of
previous year

14 Earning Per Share(before

& after extraordinary

items)(of

Rs. 10 each)(not annualised)

Basic and diluted Rs,

Notes: 1. The accounting standard regarding segment reporting is not applicable to the company as there is no segment.
2. The above results have been reviewed by the audit conunittee & approved by the Board of Directors at there respective meetings
held on 14th August 2016.
3. The figures of last quarter are the balancing figures between audited figures in respect of the full financial year and the published
year-to-date figures upto the third quarter of the current financial year.
4. Corrosponding

previous period figures are regrouped/rearranged

whereever necessary, to make them comparable.

By order of the Board

Managing
Date:

14-08-2016

Place: Ahmedabad

0.00

before Taxes but

items ( 5-6)

from Ordinary

10 Tax Expence
II Net Profit(Loss)

Activities

Director

DIN-0228926I
Add-A-727,

Sarita Vihar,

New Delhi-I 10076

OMKAR PHARMACHEM LIMITED

CIN L24231GJ1995PLC025276
501, Mahakant Building,
Opp, V.S. Hospital,
Ashram road, Ellisbridge,
Ahmedabad-380 006.
Website www.omkarpharmachem.co.in
Email investors.opl@gmaiI.com

Date: 14/08/2016
To,
Bombay Stock Exchange Limited,
Phiroz [eejeebhoy Towers,
Dalal Street,
Mumbai-400001
Sub: Submission of Limited Review Report for the Quarter ended on 30th
June. 2016
Company Scrip Code: 532167
Dear Sir,
As per Regulation 33 of the of the SEBI (Listing Obligation And Disclosure
Requirement) Regulation 2015, please find enclosed herewith the Copy of the
Limited Review Report issued by M/s Rajesh J. Shah & Associates, Chartered
Accountants, Statutory Auditors of the Company on the Unaudited Quarterly
Financial Results of the company, for the period ending on 30th June, 2016.
Thanking You,
Yours faithfully,
For Omkar Pharmachem Limited

~~

(Anurag Sharma)
Managing Director
DIN 02289261
Add: A-727, Sarita Vihar, New Delhi, 110076
Encl: a/a

H*j*sh i. 5h*fr: & &*s**E*t**

e h + rt* :"*

.&-r- :_ r:, r_;

r:i ;

:_,.r

Limited review report to The Board of Directors of Omkar Pharmachem

Limited for quarter ended on SOth June, 2016
We have reviewed the accompanying statement of unaudited linancial results of
Omkar Pharmachem Limited for the quarter ended on 30ft June, 2016. This
statement is the responsibility of the Company's management and has been
approved by the Board of Directors. Our responsibility is to issue a report on
these financial statements based on our review.

We conducted our review in accordance with the Standard on

Review
Engagement (SRE) 24OO, Engagements to Reuiew Financial Statements issued by
the Institute of Chartered Accountants of India. This standard requires that we
plan and perform the review to obtain moderate assurance as to whether the

financial statements are free of material misstatement. A review is limited

primarily to inquiries of company personnel and analytical procedures applied to
financial data and; thus provides less assurance than an audit. We have not
performed an audit and accordingly, we do not express an audit opinion.

Based on our review conducted as above, nothing has come to our notice that
causes us to believe that the accompanying statement of unaudited financial
results prepared in accordance with applicable accounting standards and other
recognized accounting practices and policies has not dlsclosed the information
required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015 including the manner in which
it is to be disclosed, or that it contains any material misstatement.

For Rajesh J. Shah & Associates

Chartered Accountants
FRN

Place: Ahmedabad
Date z 1410812o16

ros407fu

A,*\*<v'
CA Jiinit R Shah
Partner

B-1L0-111, Gopal Palace, Opp. Ocean Park, Nr. Nehrunagar BRTS Stop, Nehrunagar-satellite Road,Satellite, Ahmedabad-3g0015
Tel.No. a79-2676os37 / 26760537 / 26767637 M. No. (KBP) 94260 08343, (RJS) 98240 4s695,
info@rajeshjshahca.com I rjshah-ca@yahoo.com www.rajeshjshahca.com / rajeshjshahassociates.icai.org.in